Indefinite Delivery Contract SPE2DR25D9970
Award Date 11/13/25
Last Date to Order 11/13/36
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical...
- The federal contract IDV award to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $499,999,999 contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs...
- The federal contract IDV award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, covers a wide range of pharmaceutical products and medical supplies to support the medical needs of Department of Defense (DoD) healthcare facilities and the U.S. Coast Guard. The single-award Indefinite Delivery Contract (IDC), valued at $499,999,999 and valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic...
- The federal contract IDV awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is an Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The purpose of this IDC is to provide the DLA with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military...
- The federal contract IDV award to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...
- The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The IDC has a ceiling value of $499,999,999 and is valid through November 2026. Under this contract, DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government customers. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications,...
- The key products and services being delivered under this federal contract IDV award are pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract is held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract was awarded by the Defense Logistics Agency (DLA) as a single-award Indefinite Delivery Contract (IDC) under the SPE2DB program,...
- The federal contract IDV award to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...